ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00367458
Recruitment Status : Completed
First Posted : August 23, 2006
Last Update Posted : December 1, 2009
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2008
  Actual Study Completion Date : June 2008

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 28, 2010
(Canceled - Date Unknown)
January 29, 2010
February 19, 2010
2 April 14, 2010
May 4, 2010
3 June 16, 2010
July 12, 2010
4 July 15, 2010
(Canceled - Date Unknown)
July 16, 2010
August 20, 2010
5 September 9, 2011
October 13, 2011
6 March 27, 2017
May 5, 2017